Translational infidelity and human cancer: Role of the PTI-1 oncogene

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 1, 1999, Pages 151-162

  Gopalkrishnan, Rahul V ^a   Su, Zao Zhong ^a   Goldstein, Neil I ^b   Fisher, Paul B ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b GenQuest Incorporated   (United States)

Author keywords

Elongation factor 1 ; Oncogene; Rapid expression cloning; Translational infidelity

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; ELONGATION FACTOR 1ALPHA; RIBOSOME RNA;

AMINO TERMINAL SEQUENCE; CANCER GENETICS; CARCINOGENESIS; CODON; EUKARYOTE; GENE EXPRESSION; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID; MALE; MOUSE; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; ONCOGENE; PHENOTYPE; POINT MUTATION; PROKARYOTE; PROSTATE TUMOR; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTISENSE ELEMENTS (GENETICS); CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; ONCOGENE PROTEINS; PEPTIDE ELONGATION FACTOR 1; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032967845     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00138-1     Document Type: Review

References (47)

1. I.B. Rosenwald, Deregulation of protein synthesis as a mechanism of neoplastic transformation, Bioessays 18 (1996) 243-250.
2. B. Riis, S.I. Rattan, B.F. Clark, W.C. Merrick, Eukaryotic protein elongation factors, Trends Biochem. Sci. 15 (1990) 420-424.
3. N. Sonenberg, Translation factors as effectors of cell growth and tumorigenesis, Curr. Opin. Cell Biol. 5 (1993) 955-960.
4. A. Lazaris-Karatzas, K.S. Montine, N. Sonenberg, Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap, Nature 345 (1990) 544-547.
5. A. Lazaris-Karatzas, N. Sonenberg, The mRNA 5′ cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts, Mol. Cell Biol. 12 (1992) 1234-1238.
6. A. De Benedetti, B. Joshi, J.R. Graff, S.G. Zimmer, CHO cells transformed by the translation factor eIF-4E display increased c-myc expression, but require overexpression of Max for tumorigenicity, Mol. Cell Different 2 (1994) 347-372.
7. M. Tatsuka, H. Mitsui, M. Wada, A. Nagata, H. Nojima, H. Okayama, Elongation factor-1 alpha gene determines susceptibility to transformation, Nature 359 (1992) 333-336.
8. A.G. Grant, R.M. Flomen, M.L. Tizard, D.A. Grant, Differential screening of a human pancreatic adenocarcinoma lambda gt11 expression library has identified increased transcription of elongation factor EF-1 alpha in tumour cells, Int. J. Cancer 50 (1992) 740-745.
9. B. Ender, P. Lynch, Y.H. Kim, N.V. Inamdar, K.R. Cleary, M.L. Frazier, Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas, Mol. Carcinog. 7 (1993) 18-20.
10. Y. Lew, D.V. Jones, W.M. Mars, D. Evans, D. Byrd, M.L. Frazier, Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer, Pancreas 7 (1992) 144-152.
11. H.R. Bourne, D.A. Sanders, F. McCormick, The GTPase superfamily: a conserved switch for diverse cell functions, Nature 348 (1990) 125-132.
12. H.R. Bourne, D.A. Sanders, F. McCormick, The GTPase superfamily: conserved structure and molecular mechanism, Nature 349 (1991) 117-127.
13. W.C. Merrick, Mechanism and regulation of eukaryotic protein synthesis, Microbiol. Rev. 56 (1992) 291-315.
14. Y.W. Hwang, A. Sanchez, D.L. Miller, Mutagenesis of bacterial elongation factor Tu at lysine 136. A conserved amino acid in GTP regulatory proteins, J. Biol. Chem. 264 (1989) 8304-8309.
15. S. Tapio, C.G. Kurland, Mutant EF-Tu increases missense error in vitro, Mol. Gen. Genet. 205 (1986) 186-188.
16. M.G. Sandbaken, M.R. Culbertson, Mutations in elongation factor EF-1 alpha affect the frequency of frameshifting and amino acid misincorporation in Saccharomyces cerevisiae, Genetics 120 (1988) 923-934.
17. J.M. Song, S. Picologlou, C.M. Grant, M. Firoozan, M.F. Tuite, S. Liebman, Elongation factor EF-1 alpha gene dosage alters translational fidelity in Saccharomyces cerevisiae, Mol. Cell Biol. 9 (1989) 4571-4575.
18. P.B. Fisher, Enhancement of viral transformation and expression of the transformed phenotype by tumor promoters, in: T. Slaga (Ed.), Tumor Promotion and Cocarcinogenesis In Vitro: Mechanisms of Tumor Promotion, CRC Press, 1984, pp. 75-123.
19. L. Loeb, Mutator phenotype may be required for multistage carcinogenesis, Cancer Res. 51 (1991) 3075-3079.
20. J. Cavallius, S.I. Rattan, B.F. Clark, Changes in activity and amount of active elongation factor 1 alpha in aging and immortal human fibroblast cultures, Exp. Gerontol. 21 (1986) 149-157.
21. J.C. Shepherd, U. Walldorf, P. Hug, W.J. Gehring, Fruit flies with additional expression of the elongation factor EF-1 alpha live longer, Proc. Natl. Acad. Sci. USA 86 (1989) 7520-7521.
22. V.T. Marchesi, N. Ngo, In vitro assembly of multiprotein complexes containing alpha, beta, and gamma tubulin, heat shock protein HSP70, and elongation factor 1 alpha, Proc. Natl. Acad. Sci. USA 90 (1993) 3028-3032.
23. N. Shiina, Y. Gotoh, N. Kubomura, A. Iwamatsu, E. Nishida, Microtubule severing by elongation factor 1 alpha, Science 266 (1994) 282-285.
24. R. Shen, Z.Z. Su, C.A. Olsson, P.B. Fisher, Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display, Proc. Natl. Acad. Sci. USA 92 (1995) 6778-6782.
25. D.G. Blair, C.S. Cooper, M.K. Oskarsson, L.A. Eader, G.F. Vande Woude, New method for detecting cellular transforming genes, Science 218 (1982) 1122-1125.
26. R. Brown, G. Brady, J. Mattern, G. Schutz, An alternative assay system for the detection of transforming genes, Carcinogenesis 5 (1984) 1323-1328.
27. O. Fasano, D. Birnbaum, L. Edlund, J. Fogh, M. Wigler, New human transforming genes detected by a tumorigenicity assay, Mol. Cell Biol. 4 (1984) 1695-1705.
28. B.M. Sutherland, P.V. Bennett, A.G. Freeman, S.P. Moore, P.T. Strickland, Transformation of human cells by DNAs ineffective in transformation of NIH 3T3 cells, Proc. Natl. Acad. Sci. USA 82 (1985) 2399-2403.
29. Z.-z. Su, C.A. Olsson, S. Zimmer, P.B. Fisher, Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection, Anticancer Res. 12 (1992) 297-304.
30. J.S. Horoszewicz, S.S. Leong, E. Kawinski, J.P. Karr, H. Rosenthal, T.M. Chu, E.A. Mirand, G.P. Murphy, LNCaP model of human prostatic carcinoma, Cancer Res. 43 (1983) 1809-1818.
31. P. Liang, A.B. Pardee, Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction, Science 257 (1992) 967-971.
32. H.O. Madsen, K. Poulsen, O. Dahl, B.F. Clark, J.P. Hjorth, Retropseudogenes constitute the major part of the human elongation factor 1 alpha gene family, Nucleic Acids Res. 18 (1990) 1513-1516.
33. Y. Sun, J. Lin, A.E. Katz, P.B. Fisher, Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples, Cancer Res. 57 (1997) 18-23.
34. Z. Su, N.I. Goldstein, P.B. Fisher, Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes, Proc. Natl. Acad. Sci. USA 95 (1998) 1764-1769.
35. D. Hughes, J.F. Atkins, S. Thompson, Mutants of elongation factor Tu promote ribosomal frameshifting and nonsense readthrough, EMBO J. 6 (1987) 4235-4239.
36. J. Condeelis, Elongation factor 1 alpha, translation and the cytoskeleton, Trends Biochem. Sci. 20 (1995) 169-170.
37. B.S. Negrutskii, M.P. Deutscher, Channeling of aminoacyl-tRNA for protein synthesis in vivo, Proc. Natl. Acad. Sci. USA 88 (1991) 4991-4995.
38. L.I. Slobin, The role of eucaryotic factor Tu in protein synthesis. The measurement of the elongation factor Tu content of rabbit reticulocytes and other mammalian cells by a sensitive radioimmunoassay, Eur. J. Biochem. 110 (1980) 555-563.
39. G.J. Bassell, C.M. Powers, K.L. Taneja, R.H. Singer, Single mRNAs visualized by ultrastructural in situ hybridization are principally localized at actin filament intersections in fibroblasts, J. Cell Biol. 126 (1994) 863-876.
40. S. Dharmawardhane, M. Demma, F. Yang, J. Condeelis, Compartmentalization and actin binding properties of ABP-50: the elongation factor-1 alpha of Dictyostelium, Cell Motil Cytoskeleton 20 (1991) 279-288.
41. R. Kuriyama, P. Savereide, P. Lefebvre, S. Dasgupta, The predicted amino acid sequence of a centrosphere protein in dividing sea urchin eggs is similar to elongation factor (EF-1 alpha), J. Cell Sci. 95 (1990) 231-236.
42. F. Yang, M. Demma, V. Warren, S. Dharmawardhane, J. Condeelis, Identification of an actin-binding protein from Dictyostelium as elongation factor 1a, Nature 347 (1990) 494-496.
43. M. Toriyama, K. Ohta, S. Endo, H. Sakai, 51-kd protein, a component of microtubule-organizing granules in the mitotic apparatus involved in aster formation in vitro, Cell Motil Cytoskeleton 9 (1988) 117-128.
44. W. Yang, W. Burkhart, J. Cavallius, W.C. Merrick, W.F. Boss, Purification and characterization of a phosphatidylinositol 4-kinase activator in carrot cells, J. Biol. Chem. 268 (1993) 392-398.
45. B.T. Edmonds, J. Wyckoff, Y.G. Yeung, Y. Wang, E.R. Stanley, J. Jones, J. Segall, J. Condeelis, Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma, J. Cell Sci. 109 (1996) 2705-2714.
46. I. Koch, P.H. Hofschneider, F. Lottspeich, C. Eckerskorn, R. Koshy, Tumour-related expression of a translation-elongation factor-like protein, Oncogene 5 (1990) 839-843.
47. C.R. Starkey, L.S. Levy, Identification of differentially expressed genes in T-lymphoid malignancies in an animal model system, Int. J. Cancer 62 (1995) 325-331.